Stoke Therapeutics Stock Price on September 19, 2025
| STOK Stock | USD 23.61 1.12 4.53% |
If you're considering investing in Stoke Stock, it is important to understand the factors that can impact its price. As of today, the current price of Stoke Therapeutics stands at 23.61, as last reported on the 30th of September, with the highest price reaching 23.61 and the lowest price hitting 23.61 during the day. Stoke Therapeutics is not too volatile given 3 months investment horizon. Stoke Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.31, which indicates the firm had a 0.31 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.32% are justified by taking the suggested risk. Use Stoke Therapeutics Semi Deviation of 1.68, risk adjusted performance of 0.1856, and Coefficient Of Variation of 349.22 to evaluate company specific risk that cannot be diversified away. The value of Total Stockholder Equity is estimated to slide to about 193.3 M. The value of Common Stock Total Equity is estimated to slide to 2,750. At this time, Stoke Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 2.73 this year, although the value of Price To Operating Cash Flows Ratio will most likely fall to (7.20). Stoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 3.9494 | Enterprise Value Ebitda 25.4879 | Price Sales 6.6176 | Shares Float 38.2 M | Wall Street Target Price 24.2222 |
Related Headline
Black Diamond Headline on 19th of September 2025
Acquisition by Raman Prakash of 3843 shares of Black Diamond... by Raman Prakash
Filed transaction by Black Diamond Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Stoke Therapeutics Valuation on September 19, 2025
It is possible to determine the worth of Stoke Therapeutics on a given historical date. On September 19, 2025 Stoke was worth 23.38 at the beginning of the trading date compared to the closed value of 22.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Stoke Therapeutics stock. Still, in general, we apply an absolute valuation method to find Stoke Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Stoke Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Stoke Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 22.74 | 23.82 | 22.61 | 23.50 | 840,578 | |
09/19/2025 | 23.38 | 23.38 | 22.25 | 22.90 | 2,475,956 |
| 22.51 | 23.55 | 22.40 | 22.85 | 777,834 |
| Backtest Stoke Therapeutics | | | Stoke Therapeutics History | | | Stoke Therapeutics Valuation | Previous | Next |
Stoke Therapeutics Trading Date Momentum on September 19, 2025
| On September 22 2025 Stoke Therapeutics was traded for 22.85 at the closing time. The top price for the day was 23.55 and the lowest listed price was 22.40 . The trading volume for the day was 777.8 K. The trading history from September 22, 2025 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.22% . The trading price change against the current closing price is 6.38% . |
Stoke Therapeutics Fundamentals Correlations and Trends
By evaluating Stoke Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Stoke Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Stoke financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Stoke Therapeutics Stock history
Stoke Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Stoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Stoke Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Stoke Therapeutics stock prices may prove useful in developing a viable investing in Stoke Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54 M | 37.4 M | |
| Net Loss | -91 M | -86.4 M |
Stoke Therapeutics Quarterly Net Working Capital |
|
Stoke Therapeutics Stock Technical Analysis
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Stoke Therapeutics Period Price Range
Low | September 30, 2025
| High |
0.00 | 0.00 |
Stoke Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Stoke Therapeutics September 30, 2025 Market Strength
Market strength indicators help investors to evaluate how Stoke Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Stoke Therapeutics shares will generate the highest return on investment. By undertsting and applying Stoke Therapeutics stock market strength indicators, traders can identify Stoke Therapeutics entry and exit signals to maximize returns
Stoke Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Stoke Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Stoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Stoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1856 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 0.575 | |||
| Sortino Ratio | 0.4721 | |||
| Treynor Ratio | 0.6339 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.87 | Revenue Per Share | Quarterly Revenue Growth 1.86 | Return On Assets | Return On Equity |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.